Date: 2015-02-03
Type of information: R&D agreement
Compound:
Company: Moderna Therapeutics (USA - MA) Institut Pasteur (France)
Therapeutic area: Infectious diseases
Type agreement: R&D
Action mechanism:
Disease: viral diseases and bacterial diseases
Details: * On February 3, 2015, Moderna Therapeutics and the Institut Pasteur announced a long-term strategic research collaboration for the discovery and development of drugs and vaccines using Moderna’s mRNA Therapeutics™ platform. Valera, a Moderna venture company, will manage the research collaboration for Moderna. Valera is focused exclusively on the advancement of vaccines and therapeutics for the prevention and treatment of viral, bacterial and parasitic infectious diseases. Under the agreement, Valera will sponsor programs of preclinical and clinical research at the Institut Pasteur aimed at identifying and developing new approaches to combatting known and emerging viral and bacterial diseases.
Financial terms:
Latest news:
